Aemetis (NASDAQ:AMTX) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

Aemetis, Inc (NASDAQ:AMTX) shares passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.37 and traded as low as $1.45. Aemetis shares last traded at $1.46, with a volume of 946,672 shares.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Ascendiant Capital Markets reduced their target price on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Aemetis presently has an average rating of “Moderate Buy” and an average price target of $17.00.

Aemetis Trading Down 3.9%

The business has a 50-day moving average price of $2.20 and a 200 day moving average price of $2.37. The stock has a market cap of $95.73 million, a PE ratio of -0.91 and a beta of 2.29.

Aemetis (NASDAQ:AMTX) last posted its earnings results on Friday, November 7th. The specialty chemicals company reported ($0.37) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.12). The company had revenue of $59.19 million for the quarter, compared to analyst estimates of $87.79 million. On average, equities analysts predict that Aemetis, Inc will post -2.07 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Catalyst Funds Management Pty Ltd purchased a new stake in Aemetis in the second quarter valued at approximately $25,000. R Squared Ltd bought a new position in shares of Aemetis in the 2nd quarter worth $30,000. Creative Planning bought a new position in shares of Aemetis in the 2nd quarter worth $30,000. Centiva Capital LP purchased a new stake in shares of Aemetis during the 3rd quarter valued at $39,000. Finally, Ethic Inc. bought a new stake in shares of Aemetis during the 2nd quarter worth $42,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.